NCC Medical Group is an internationally recognized manufacturer specializing in advanced neurodiagnostic and neuro-monitoring technologies. Since its establishment in 1997, the company has focused on developing high-precision medical equipment designed to support neurological diagnosis, brain monitoring, and intraoperative neurophysiology.
Recognized as a National SRDI “Little Giant” enterprise, NCC represents a group of innovative technology leaders that possess core intellectual property and strong research capabilities. The SRDI designation—Specialized, Refined, Differential, and Innovational—is awarded by government authorities to companies that demonstrate exceptional technological expertise and industry leadership.
NCC’s primary research and manufacturing base is located in Shanghai, China. This facility serves as the technological powerhouse of the company, integrating advanced biomedical engineering research, product design, and precision manufacturing. Through strict quality control systems and modern production processes, NCC ensures that every neurodiagnostic system meets the highest performance and reliability standards.
To support international market expansion, NCC operates a global quality and compliance center in Singapore. This strategic hub oversees international regulatory management, product certification, and global distribution coordination. By combining research and production capabilities in China with international compliance management in Singapore, NCC has established an efficient operational structure that supports global healthcare markets.
The company’s product portfolio includes intraoperative neuro-monitoring systems, EEG and PSG diagnostic equipment, electromyography systems, and a wide range of related medical consumables. These technologies are widely used in neurology departments, sleep laboratories, research institutions, and surgical operating rooms.
NCC organizes its operations around three strategic pillars. The first pillar focuses on research and manufacturing, driving innovation in neurophysiology technology and ensuring stable large-scale production. The second pillar supports global sales and export activities, building a strong international distribution network and establishing long-term partnerships with medical institutions worldwide. The third pillar emphasizes service innovation through platforms such as the NeuGuard Service Platform and the NCC Innovation Academy.
Through continuous development and international collaboration, NCC has expanded its presence to more than fifty countries and regions. Thousands of hospitals and medical centers rely on NCC technology for neurological monitoring and diagnostic procedures. From leading teaching hospitals to regional healthcare institutions, NCC solutions are widely trusted for their reliability and performance.
In addition to product development, NCC is committed to professional education and clinical collaboration. The company operates more than thirty training and technical support centers across China, providing comprehensive training programs for clinicians, biomedical engineers, and technicians. These programs support the effective use of neurodiagnostic equipment and promote the advancement of neurophysiology practice.
Guided by the mission of safeguarding life and health, NCC continues to develop innovative technologies that support safer surgical procedures, more accurate neurological diagnosis, and improved patient care worldwide.
Copyright © NCC Medical Co., Ltd. - Privacy policy